Cécile Goujard

14.9k total citations · 1 hit paper
230 papers, 8.2k citations indexed

About

Cécile Goujard is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Cécile Goujard has authored 230 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Virology, 128 papers in Infectious Diseases and 60 papers in Epidemiology. Recurrent topics in Cécile Goujard's work include HIV Research and Treatment (138 papers), HIV/AIDS drug development and treatment (85 papers) and HIV/AIDS Research and Interventions (81 papers). Cécile Goujard is often cited by papers focused on HIV Research and Treatment (138 papers), HIV/AIDS drug development and treatment (85 papers) and HIV/AIDS Research and Interventions (81 papers). Cécile Goujard collaborates with scholars based in France, United States and Germany. Cécile Goujard's co-authors include Laurence Meyer, Jean‐François Delfraissy, Christiane Deveau, Christine Rouzioux, Olivier Lambotte, Marie‐Laure Chaix, Martine Sinet, Faroudy Boufassa, Yassine Taoufik and Alain Venet and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Cécile Goujard

221 papers receiving 8.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression

1996 423 citations Anne Dulioust, Cécile Goujard et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cécile Goujard France	49	5.0k	4.0k	2.8k	2.0k	1.0k	230	8.2k
Jean‐François Delfraissy France	53	5.7k 1.1×	5.2k 1.3×	3.3k 1.2×	2.7k 1.3×	1.2k 1.2×	193	10.2k
Michael A. Polis United States	43	4.3k 0.9×	3.5k 0.9×	2.8k 1.0×	2.9k 1.4×	832 0.8×	143	8.6k
Nelson L. Michael United States	52	5.1k 1.0×	4.1k 1.0×	2.8k 1.0×	2.0k 1.0×	662 0.7×	269	8.6k
Ronald J. Bosch United States	51	6.8k 1.4×	6.1k 1.5×	2.0k 0.7×	2.0k 1.0×	2.4k 2.4×	222	10.9k
Stéphane Blanche France	52	2.8k 0.6×	5.1k 1.3×	2.2k 0.8×	2.8k 1.4×	1.4k 1.4×	254	9.6k
Laurence Weiss France	42	2.5k 0.5×	1.9k 0.5×	2.7k 0.9×	1.3k 0.6×	643 0.6×	140	5.6k
Willy Rozenbaum France	43	5.8k 1.2×	5.0k 1.2×	2.7k 1.0×	3.1k 1.6×	1.9k 1.9×	169	11.0k
Ronald Brookmeyer United States	26	4.0k 0.8×	3.2k 0.8×	1.5k 0.5×	1.4k 0.7×	378 0.4×	43	7.4k
Joseph B. Margolick United States	46	5.4k 1.1×	4.2k 1.0×	2.8k 1.0×	2.3k 1.1×	695 0.7×	134	9.1k
Savita Pahwa United States	54	4.7k 1.0×	2.9k 0.7×	5.4k 1.9×	3.3k 1.7×	889 0.9×	360	10.9k

Countries citing papers authored by Cécile Goujard

Since Specialization

Citations

This map shows the geographic impact of Cécile Goujard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Goujard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Goujard more than expected).

Fields of papers citing papers by Cécile Goujard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cécile Goujard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Goujard. The network helps show where Cécile Goujard may publish in the future.

Co-authorship network of co-authors of Cécile Goujard

This figure shows the co-authorship network connecting the top 25 collaborators of Cécile Goujard. A scholar is included among the top collaborators of Cécile Goujard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cécile Goujard. Cécile Goujard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hardy‐Léger, Isabelle, Mathilde de Menthon, Ariane Laparra, et al.. (2023). Psychiatric Symptoms and Cognitive Disorders in Behçet’s Disease: A Single-Center, Cross-Sectional Study. Journal of Clinical Medicine. 12(9). 3149–3149. 6 indexed citations

Venditti, Laura, Cécile Cauquil, Clovis Adam, et al.. (2023). Neuropathies périphériques au cours des maladies de système : partie I (connectivites et granulomatoses). La Revue de Médecine Interne. 44(4). 164–173.

Lécuroux, Camille, Véronique Avettand-Fènoël, Faroudy Boufassa, et al.. (2021). CXCR3 and CXCR5 are highly expressed in HIV‐1‐specific CD8 central memory T cells from infected patients. European Journal of Immunology. 51(8). 2040–2050. 3 indexed citations

Noël, Nicolas, Béatrice Jacquelin, Nicolas Huot, et al.. (2018). Interferon-associated therapies toward HIV control: The back and forth. Cytokine & Growth Factor Reviews. 40. 99–112. 17 indexed citations

Boccara, Franck, Laurence Meyer, Cécile Goujard, et al.. (2017). Impact of protease inhibitors on circulating PCSK9 levels in HIV-infected antiretroviral-naive patients from an ongoing prospective cohort. AIDS. 31(17). 2367–2376. 19 indexed citations

Protière, Christel, Bruno Spire, Marion Mora, et al.. (2017). Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC). PLoS ONE. 12(11). e0187489–e0187489. 28 indexed citations

Noël, Nicolas, Elina Teicher, Yann Quertainmont, et al.. (2016). Recurrent obstructive acute pyelonephritis: A rare form of Actinotignum (Actinobaculum) schaalii infection in a HIV-1 infected patient. Anaerobe. 43. 75–77. 5 indexed citations

Noël, Nicolas, Félix Ackermann, Jérôme Le Pavec, et al.. (2015). Life-threatening Hughes-Stovin syndrome: The Yin and Yang of anticoagulation therapy. Joint Bone Spine. 83(4). 459–460. 3 indexed citations

Moreau, Alain, Laurence Meyer, Cécile Goujard, et al.. (2014). Adaptation of HIV-1 Envelope Glycoprotein gp120 to Humoral Immunity over the Course of the Epidemic. AIDS Research and Human Retroviruses. 30(S1). A224–A224.

10.

Leclercq, Pascale, et al.. (2012). High Prevalence and Impact on the Quality of Life of Facial Lipoatrophy and Other Abnormalities in Fat Tissue Distribution in HIV-Infected Patients Treated with Antiretroviral Therapy. AIDS Research and Human Retroviruses. 29(5). 761–768. 25 indexed citations

11.

Almodóvar, Sharilyn, Rob Knight, Amanda A. Allshouse, et al.. (2011). Human Immunodeficiency Virus nef Signature Sequences Are Associated with Pulmonary Hypertension. AIDS Research and Human Retroviruses. 28(6). 607–618. 42 indexed citations

12.

Tsiara, Chrissa, Georgios K. Nikolopoulos, Pantelis G. Bagos, et al.. (2011). Impact of HIV Type 1 DNA Levels on Spontaneous Disease Progression: A Meta-Analysis. AIDS Research and Human Retroviruses. 28(4). 366–373. 17 indexed citations

13.

Galimand, Julie, Pierre Frange, Christine Rouzioux, et al.. (2010). Short Communication: Evidence of HIV Type 1 Complex and Second Generation Recombinant Strains Among Patients Infected in 1997–2007 in France: ANRS CO06 PRIMO Cohort. AIDS Research and Human Retroviruses. 26(6). 645–651. 16 indexed citations

14.

Ségéral, Olivier, Janin Nouhin, Chanroeurn Hak, et al.. (2010). Short Communication: Three Years Follow-Up of First-Line Antiretroviral Therapy in Cambodia: Negative Impact of Prior Antiretroviral Treatment. AIDS Research and Human Retroviruses. 27(6). 597–603. 15 indexed citations

15.

Vidal, Nicole, Pierre Frange, Marie‐Laure Chaix, et al.. (2008). Characterization of an Old Complex Circulating Recombinant Form, CRF27_cpx, Originating from the Democratic Republic of Congo (DRC) and Circulating in France. AIDS Research and Human Retroviruses. 24(2). 315–321. 14 indexed citations

16.

Goujard, Cécile, Fabienne Marcellin, Houria Hendel‐Chavez, et al.. (2007). Interruption of Antiretroviral Therapy Initiated during Primary HIV-1 Infection: Impact of a Therapeutic Vaccination Strategy Combined with Interleukin (IL)-2 Compared with IL-2 Alone in the ANRS 095 Randomized Study. AIDS Research and Human Retroviruses. 23(9). 1105–1113. 39 indexed citations

17.

Lévy, Yves, Christine Durier, Anne‐Sophie Lascaux, et al.. (2006). Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals. AIDS. 20(3). 405–413. 65 indexed citations

18.

Hémery, F., Cécile Goujard, Jean François Delfraissy, et al.. (2005). Beneficial Effect of Highly Active Antiretroviral Therapy on the Prognosis of AIDS-Related Systemic Non-Hodgkin Lymphomas. AIDS Research and Human Retroviruses. 21(3). 214–220. 15 indexed citations

19.

Lambotte, Olivier, Moana Gelu‐Siméon, G. Maigné, et al.. (2004). Pegylated interferon alpha-2a-associated life-threatening Evans' syndrome in a patient with chronic hepatitis C. Journal of Infection. 51(3). e113–e115. 16 indexed citations

20.

Doisne, Jean‐Marc, Alejandra Urrutia, Christine Lacabaratz, et al.. (2004). CD8+ T Cells Specific for EBV, Cytomegalovirus, and Influenza Virus Are Activated during Primary HIV Infection. The Journal of Immunology. 173(4). 2410–2418. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact